- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
Authors
Keywords
-
Journal
Rheumatology and Therapy
Volume 7, Issue 3, Pages 433-446
Publisher
Springer Science and Business Media LLC
Online
2020-06-02
DOI
10.1007/s40744-020-00212-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Update on Lupus Nephritis: Core Curriculum 2020
- (2020) Samir V. Parikh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus
- (2019) Tatiana Martínez et al. AUTOIMMUNITY REVIEWS
- Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
- (2019) Per Eriksson et al. Frontiers in Pharmacology
- Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
- (2019) Y K Onno Teng et al. BMJ Open
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker parameters in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study
- (2019) Sudha Visvanathan et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of vitamin D supplementation in patients with systemic lupus erythematosus: A meta-analysis of randomized controlled trials
- (2019) Ronghao Zheng et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies
- (2019) Andreas Schwarting et al. ANNALS OF THE RHEUMATIC DISEASES
- Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus
- (2019) Ana Vásquez et al. CELLULAR SIGNALLING
- The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
- (2019) M Frodlund et al. LUPUS
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
- (2019) Martin Aringer et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis
- (2019) Dorian Parisis et al. AUTOIMMUNITY REVIEWS
- Association between circulating 25‐hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta‐analysis
- (2019) Shi‐Yang Guan et al. International Journal of Rheumatic Diseases
- CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
- (2019) Hong Qin et al. Science Translational Medicine
- The coenzyme Q10 analog idebenone attenuates murine lupus by improving mitochondrial metabolism and reducing inflammation
- (2019) Luz P. Blanco et al. Arthritis & Rheumatology
- Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent
- (2019) Alessia Alunno et al. Cells
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
- (2019) Alexis Jones et al. BMJ Open
- CAR T-cell Therapy: A New Era in Cancer Immunotherapy
- (2018) Miliotou N. Androulla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
- (2018) Luca Iaccarino et al. JOURNAL OF AUTOIMMUNITY
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- (2018) Zhi-Wei Lai et al. LANCET
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus
- (2018) Tomonori Ishii et al. Modern Rheumatology
- Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus
- (2018) Domenico Paolo Emanuele Margiotta et al. PLoS One
- Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
- (2018) Domenico Paolo Emanuele Margiotta et al. BMC Nephrology
- Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
- (2018) Joan T. Merrill et al. Arthritis & Rheumatology
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
- (2018) Joan T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men
- (2017) A Schwarting et al. LUPUS
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
- (2017) Eoghan M McCarthy et al. RHEUMATOLOGY
- New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab
- (2017) Chrysanthi Staveri et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study
- (2017) Sophie Grabar et al. VACCINE
- Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
- (2017) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Remission in systemic lupus erythematosus: durable remission is rare
- (2016) Theresa R Wilhelm et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review
- (2016) Andreas Kronbichler et al. AUTOIMMUNITY REVIEWS
- Hydroxychloroquine in systemic lupus erythematosus (SLE)
- (2016) C. Ponticelli et al. Expert Opinion On Drug Safety
- Multitarget Therapy for Induction Treatment of Lupus Nephritis
- (2015) Zhihong Liu et al. ANNALS OF INTERNAL MEDICINE
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) J T Merrill et al. ANNALS OF THE RHEUMATIC DISEASES
- Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
- (2015) Kate Franklyn et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
- (2015) D A Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
- (2015) Alfred L. Garfall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic lupus erythematosus: a therapeutic challenge for the XXI century
- (2014) Manuel F. Ugarte-Gil et al. CLINICAL RHEUMATOLOGY
- Intravenous Immunoglobulin in the Therapeutic Armamentarium of Systemic Lupus Erythematosus
- (2014) Rajalingham Sakthiswary et al. MEDICINE
- Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity
- (2014) C Sjöwall et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
- (2013) Vibeke Strand et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Oxidative stress in the pathology and treatment of systemic lupus erythematosus
- (2013) Andras Perl Nature Reviews Rheumatology
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
- (2012) Zhi-Wei Lai et al. ARTHRITIS AND RHEUMATISM
- BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
- (2012) Fabien B Vincent et al. IMMUNOLOGY AND CELL BIOLOGY
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity
- (2011) G. H. Stummvoll et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus
- (2010) Kai W. Bekar et al. ARTHRITIS AND RHEUMATISM
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- (2010) Corinna E. Weckerle et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Prednisone, Lupus Activity, and Permanent Organ Damage
- (2009) M. THAMER et al. JOURNAL OF RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now